Skip to content
healthcare.dev

POTELIGEO

NDC 42747-761, mogamulizumab-kpkc, injection, from Kyowa Kirin, Inc..

Product NDC
42747-761
Status
Listed
Labeler
Kyowa Kirin, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761051
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42747-761 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MOGAMULIZUMAB4 mg/mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Chemokine Receptor Type 4 Interaction [EPC]; Chemokine Receptor Type 4 Interactions [MoA]; Monoclonal Antibody [EPC]

Package NDCNDC-11Package
42747-761-01427470761011 VIAL, GLASS in 1 CARTON (42747-761-01) / 5 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e53960ab-42a1-40d1-9c7d-eb013fe7f18f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=42747-761

Use it

Look up 42747-761 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42747-761 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42747-761. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.